[go: up one dir, main page]

WO2004038019A3 - Dnazyme - Google Patents

Dnazyme Download PDF

Info

Publication number
WO2004038019A3
WO2004038019A3 PCT/GB2003/004614 GB0304614W WO2004038019A3 WO 2004038019 A3 WO2004038019 A3 WO 2004038019A3 GB 0304614 W GB0304614 W GB 0304614W WO 2004038019 A3 WO2004038019 A3 WO 2004038019A3
Authority
WO
WIPO (PCT)
Prior art keywords
dnazyme
mutant polynucleotides
dnazymes
cleaving
flanking regions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2003/004614
Other languages
English (en)
Other versions
WO2004038019A2 (fr
Inventor
David Beeson
Matthew Wood
Amr Abdelgany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to AU2003274382A priority Critical patent/AU2003274382A1/en
Publication of WO2004038019A2 publication Critical patent/WO2004038019A2/fr
Publication of WO2004038019A3 publication Critical patent/WO2004038019A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des DNAzymes conçus pour le ciblage d'allèles mutants et le clivage en un site distant du site de mutation. Les DNAzymes se lient sélectivement avec un allèle mutant et comprennent un motif catalytique central ainsi que deux régions flanquantes. Au moins une de ces régions présente une séquence polynucléotidique complémentaire d'une région qui comporte la mutation dans l'allèle mutant.
PCT/GB2003/004614 2002-10-23 2003-10-23 Dnazyme Ceased WO2004038019A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003274382A AU2003274382A1 (en) 2002-10-23 2003-10-23 Dnazyme cleaving mutant polynucleotides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0224663A GB0224663D0 (en) 2002-10-23 2002-10-23 DNAzyme
GB0224663.5 2002-10-23

Publications (2)

Publication Number Publication Date
WO2004038019A2 WO2004038019A2 (fr) 2004-05-06
WO2004038019A3 true WO2004038019A3 (fr) 2004-08-19

Family

ID=9946431

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/004614 Ceased WO2004038019A2 (fr) 2002-10-23 2003-10-23 Dnazyme

Country Status (3)

Country Link
AU (1) AU2003274382A1 (fr)
GB (1) GB0224663D0 (fr)
WO (1) WO2004038019A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2898200A1 (fr) * 2013-01-14 2014-07-17 Academia Sinica Adn a activite catalytique servant a supprimer l'expression de l'egfr

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037013A1 (fr) * 1996-04-02 1997-10-09 Commonwealth Scientific And Industrial Research Organisation Ribozymes asymetriques en forme de tete de marteau

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037013A1 (fr) * 1996-04-02 1997-10-09 Commonwealth Scientific And Industrial Research Organisation Ribozymes asymetriques en forme de tete de marteau

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CAIRNS M J ET AL: "Nucleic acid mutation analysis using catalytic DNA", NUCLEIC ACIDS RESEARCH, vol. 28, no. 3, 1 February 2000 (2000-02-01), pages E9, XP002233619, ISSN: 0305-1048 *
PHYLACTOU L A ET AL: "HAMMERHEAD RIBOZYMES TARGETED TO THE FBN1 MRNA CAN DISCRIMINATE A SINGLE BASE MISMATCH BETWEEN RIBOZYME AND TARGET", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 249, no. 3, 1998, pages 804 - 810, XP000914845, ISSN: 0006-291X *
PHYLACTOU L A ET AL: "Potential therapy paradigms for Marfan syndrome", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 8, no. 7, 1999, pages 983 - 993, XP008031688, ISSN: 1354-3784 *
PHYLACTOU LEONIDAS A ET AL: "Ribozymes as therapeutic tools for genetic disease", HUMAN MOLECULAR GENETICS, vol. 7, no. 10, 1998, pages 1649 - 1653, XP002285064, ISSN: 0964-6906 *
SANTORO S W ET AL: "MECHANISM AND UTILITY OF AN RNA-CLEAVING DNA ENZYME", BIOCHEMISTRY, vol. 37, no. 22, September 1998 (1998-09-01), pages 13330 - 13342, XP001009842, ISSN: 0006-2960 *
SZYRACH M ET AL: "Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 268, no. 12, June 2001 (2001-06-01), pages 3550 - 3557, XP002251944, ISSN: 0014-2956 *
WOOD M J ET AL: "RIBOZYMES AND SIRNA FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM", CURRENT OPINION IN MOLECULAR THERAPEUTICS, vol. 5, no. 4, 2003, pages 383 - 388, XP009029174, ISSN: 1464-8431 *

Also Published As

Publication number Publication date
AU2003274382A8 (en) 2004-05-13
WO2004038019A2 (fr) 2004-05-06
AU2003274382A1 (en) 2004-05-13
GB0224663D0 (en) 2002-12-04

Similar Documents

Publication Publication Date Title
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
SG142154A1 (en) Methods for genomic analysis
WO2002086088A3 (fr) Polymerases a activite de commutation de charges et methodes permettant de produire lesdites polymerases
WO2005042716A3 (fr) Oligonucleotides se liant a des acides nucleiques
WO1998003677A3 (fr) Polymorphisme du gene pit-1 et detection de caracteres chez des animaux
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
IL158415A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-17 GENE
WO2004038019A3 (fr) Dnazyme
WO1998033937A3 (fr) SEQUENCE GENOMIQUE DU GENE RECEPTEUR ν-OPIOIDE HUMAIN, AINSI QUE SES VARIANTES, POLYMORPHISMES ET MUTATIONS
WO2001040521A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2001048245A3 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
WO2001023410A3 (fr) Isogenes cibles a usage medicamenteux: polymorphismes dans le gene d'interleukine
AU2001278509A1 (en) Nucleotide sequences which code for the atr43 gene
WO2002083733A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifn$g(a)-6
WO2005123961A3 (fr) Approches pour identifier des mutations associees au cancer colorectal hereditaire sans polypose
AU2001293808A1 (en) Nucleotide sequences which code for the atr61 gene
WO2001096535A3 (fr) Acide nucleique codant pour un site de liaison d'une proteine kinase de la cascade de signalisation mitogene de l'enzyme catalysant la glycolyse
AU2002212255A1 (en) Nucleotide sequences which code for the trub gene
AU2001293730A1 (en) Nucleotide sequences which code for the chra gene
WO2001014415A3 (fr) Gènes egfh2 et produits géniques
WO2006065971A3 (fr) Compositions et methodes concernant l'amplification et la detection de polynucleotides
WO2000029622A3 (fr) Acides nucleiques contenant des polymorphismes d'un nucleotide unique et utilisation de ces acides nucleiques
WO2001051670A3 (fr) Acides nucleiques renfermant des polymorphismes de nucleotide simple et procede d'utilisation associe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP